Contact us

Taylor Wessing LLP

Experts

10

Filter by: Practice area
Alexander Erskine
Alexander Erskine
Taylor Wessing LLP
Alice Anderson
Alice Anderson
Solicitor
Taylor Wessing LLP
Alison Cartin
Alison Cartin
Associate Director
Taylor Wessing LLP
Alison Dennis
Alison Dennis
Partner, International Co-Head Life Sciences and Healthcare
Taylor Wessing LLP
Alistair Watson
Alistair Watson
Taylor Wessing LLP
Katie Chandler
Katie Chandler
Taylor Wessing LLP
Mark Smith
Mark Smith
Taylor Wessing LLP
Nick Warr
Nick Warr
Partner
Taylor Wessing LLP
Paul England
Dr Paul England
Solicitor
Taylor Wessing LLP
Roland Mallinson
Roland Mallinson
Partner
Taylor Wessing LLP
Contributions by Taylor Wessing LLP

5

Anti-counterfeiting in the UK
Anti-counterfeiting in the UK
Practice notes

This Practice Note examines the main routes of legal action that can be taken against the UK trade in counterfeit goods. It covers: the roles of customs authorities, Trading Standards and the police; civil litigation for trade mark infringement; and private criminal prosecution.

Madrid international trade mark system
Madrid international trade mark system
Practice notes

This Practice Note provides a brief outline of the Madrid international trade mark system explaining the procedure for application and registration of international trade marks. It covers the role of the World Intellectual Property Organisation, the Madrid Agreement 1891 and the related Madrid Protocol.

Parallel imports
Parallel imports
Practice notes

This Practice Note sets out the law relating to parallel imports (or grey market goods) in the context of trade marks and considers when a trade mark owner’s rights will be exhausted and when the right holder is able to prevent non-EEA grey market goods from being marketed in the UK. It also provides practical guidance upon the law relating to the repackaging of goods, as per the requirements set out in the Bristol-Myers Squibb case (commonly referred to as the BMS conditions).

Protectors
Protectors
Practice notes

This Practice Note written by Alison Cartin, of Taylor Wessing LLP explains the role of the protector of a trust, the reasons why a settlor might choose to appoint a protector and the powers and liabilities of a protector. It also explains how to appoint a protector and issues to consider when drafting a trust with a protector.

Other Work
European Union trade mark registration—flowchart
European Union trade mark registration—flowchart

This Flowchart provides an overview of the European Union Trade Mark registration process as implemented by the European Union Intellectual Property Office (EUIPO). It covers the key stages of application; publication; opposition; registration; cancellation and expiry.

Contributions by Taylor Wessing LLP Experts

5

Clinical evaluation and performance evaluation of medical devices in the EU
Clinical evaluation and performance evaluation of medical devices in the EU
Practice notes

This Practice Note discusses key changes to the requisite clinical evaluation and performance evaluation processes of medical devices under the EU regulatory regime introduced by Regulation (EU) 2017/745, the Medical Devices Regulation (MDR) and Regulation (EU) 2017/746, the In Vitro Diagnostic Medical Devices Regulation (IVDR). This note considers the practical implications of the changes to definitions and requirements for clinical data, clinical evidence and, in particular, clinical investigations for assessing the health and safety of medical devices under the MDR and IVDR in Europe.

Introduction to the EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation
Introduction to the EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation
Practice notes

This Practice Note provides an overview of Regulation (EU) 2017/745, the Medical Devices Regulation and Regulation (EU) 2017/746, the In Vitro Diagnostic Medical Devices Regulation, and the process of placing a device on the EU market.

Post-market surveillance of medical devices in the EU
Post-market surveillance of medical devices in the EU
Practice notes

This Practice Note examines the EU regulatory regime introduced by Regulation (EU) 2017/745, the Medical Devices Regulation (MDR) and Regulation (EU) 2017/746, the In Vitro Diagnostic Medical Devices Regulation (IVDR), in relation to its reform and strengthening of a mandatory comprehensive post-market surveillance system that monitors and records the real-life use of medical devices after authorisation to feedback into a device’s official safety profile and certification thereby ensuring their continuing safety.

The EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation—EUDAMED and economic operators
The EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation—EUDAMED and economic operators
Practice notes

This Practice Note considers the European database on medical devices (EUDAMED) and the obligations of economic operators, such as manufacturers, distributors and importers of medical devices, under Regulation (EU) 2017/745, the Medical Devices Regulation and Regulation (EU) 2017/746, the In Vitro Diagnostic Medical Devices Regulation.

The EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation—scope, classification of devices and Notified Bodies
The EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation—scope, classification of devices and Notified Bodies
Practice notes

This Practice Note examines the scope and classification of devices under Regulation (EU) 2017/745, the Medical Devices Regulation and Regulation (EU) 2017/746, the In Vitro Diagnostic Medical Devices Regulation, conformity assessment procedures and designation and monitoring of Notified Bodies.

If you expected to see yourself on this page, click here.